Clinical Trial: Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07133815) titled 'Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia' on Aug. 14.

Brief Summary: A multicenter, single arm, open label phase II clinical study evaluating the long-term efficacy and safety of SHR-1918 in homozygous familial hypercholesterolemia patients

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Homozygous Familial Hypercholesterolemia

Intervention: DRUG: SHR-1918

SHR-1918

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd

Published by HT Digital Content Services with permission from Health Daily Digest...